Search BioPortfolio:
BioPortfolio
Web
Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
BioNews - BioPortfolio's News Portal
CBS MarketWatch Biotechnology and Pharmaceutical News and Headlines
Sign-up to BioPortfolio's
CBS MarketWatch Biotechnology and Pharmaceutical news alerts
.
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Sales decline for ImClone's Erbitux? - Drug experienced sequential drop in July, researcher says
CBS MarketWatch:
similar ...
ImClone leads biopharma sell-off
CBS MarketWatch:
similar ...
Bill Gates invests in Corus Pharma - Billionaire holds stake in fresh IPO
CBS MarketWatch:
similar ...
Report/ J&J gets FDA OK for stent
CBS MarketWatch:
similar ...
MedImmune gains on Chiron flu woes
CBS MarketWatch:
similar ...
Flu vaccine delay not seen as problem - CDC/ Everyone who needs one ultimately will get one
CBS MarketWatch:
similar ...
Chiron downgraded over Fluvirin - Shipment delays prompt Deutsche, Baird ratings moves
CBS MarketWatch:
similar ...
California pharmacies sue drugmakers - 15 pharmaceuticals sued over prices
CBS MarketWatch:
similar ...
Merck lower on Vioxx study; Gilead gains
CBS MarketWatch:
similar ...
Merck lower on Vioxx study; Gilead gains
CBS MarketWatch:
similar ...
Biopharma dips; Merck off on Vioxx
CBS MarketWatch:
similar ...
FDA may sue states over drug imports - Vermont's action prompts feds to counter with legal talk
CBS MarketWatch:
similar ...
Cyberonics ups earnings outlook - Company mulling FDA appeal options as shares slip
CBS MarketWatch:
similar ...
Biotech, pharma finish higher
CBS MarketWatch:
similar ...
Human Genome rises on trial kickoff
CBS MarketWatch:
similar ...
StemCells, Medarex up in biotech mix
CBS MarketWatch:
similar ...
Report/ FDA eyes Boston Scientific plant
CBS MarketWatch:
similar ...
DOJ probes medical suppliers - Prosecutors weigh whistleblower suit vs. Becton
CBS MarketWatch:
similar ...
Analyst/ Mylan-King merger at risk - Icahn seen potentially upsetting deal via equity stake
CBS MarketWatch:
similar ...
Mylan dips on patent suit loss
CBS MarketWatch:
similar ...
